Konsyl Pharmaceuticals Inc.

Is Konsyl Pharmaceuticals publicly traded?
No. The company is privately held and family-influenced, with no stock listing or public shareholders. It publishes no financial statements.

Who owns Konsyl Pharmaceuticals?
The company is privately owned and operates independently from Easton, Maryland. It has no parent company and no outside corporate ownership.

When was Konsyl Pharmaceuticals founded?
The company was founded in 1934 and introduced its original psyllium fiber product that year, operating continuously since.

What does Konsyl Pharmaceuticals make?
The company makes psyllium fiber supplements under the Konsyl brand, including original powder, capsules, Daily Psyllium Fiber, Easy Mix, and Konsyl Balance formulations.

How does Konsyl compete with Metamucil?
Konsyl offers the same psyllium active ingredient as Metamucil in formulations without added sugars or dyes, positioned around purity. It competes at much smaller scale through pharmacy and natural retail channels rather than mass advertising.

Where is Konsyl Pharmaceuticals located?
The company is headquartered in Easton, Maryland, on the Eastern Shore, where it has been based since its founding.

Konsyl Pharmaceuticals was established in 1934 and introduced its original psyllium fiber product the same year. Psyllium husk, derived from the seeds of Plantago ovata grown primarily in India, was gaining recognition for its effectiveness as a bulk-forming fiber for digestive regularity.

The company built its early business on physician and pharmacist recommendation, marketing its original formula as a natural, additive-free fiber supplement. Its Easton, Maryland base has remained its headquarters throughout, reflecting the continuity of a business that never scaled beyond its core product.

The fiber supplement category transformed in the postwar era as Metamucil, originally a G.D. Searle product and later Procter & Gamble's flagship fiber brand, invested heavily in national advertising and became the category's dominant name. Konsyl, without comparable marketing resources, settled into a secondary position sustained by professional channel loyalty and its purity positioning.

Through the late twentieth and early twenty-first centuries, the company expanded its line to include capsules, daily-use formulations, Easy Mix blends, and Konsyl Balance, a product formulated for digestive and blood sugar support. It maintained continuous operation through the industry consolidation that moved most competing brands into large consumer health companies.

In recent years, the company has been cited in NIH fiber supplement guidance alongside Metamucil as a principal psyllium option, a recognition that carries clinical weight beyond its commercial size. As of 2026, it continues operating independently from Easton.